Linton MF - Search Results

1

Kon V, Linton MF. Kon V, et al. Among authors: linton mf. J Am Soc Nephrol. 2016 Feb;27(2):341-4. doi: 10.1681/ASN.2015070793. Epub 2015 Aug 28. J Am Soc Nephrol. 2016. PMID: 26319243 Free PMC article. No abstract available.

2

Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.

Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I. Nishida M, et al. Among authors: linton mf. J Clin Invest. 2002 Dec;110(12):1859-68. doi: 10.1172/JCI15045. J Clin Invest. 2002. PMID: 12488436 Free PMC article.

3

Apolipoprotein AI as therapy for atherosclerosis: does the future of preventive cardiology include weekly injections of the HDL protein?

Fazio S, Linton MF. Fazio S, et al. Among authors: linton mf. Mol Interv. 2003 Dec;3(8):436-40. doi: 10.1124/mi.3.8.436. Mol Interv. 2003. PMID: 14993451

4

Angiotensin II amplifies macrophage-driven atherosclerosis.

Nobuhiko A, Suganuma E, Babaev VR, Fogo A, Swift LL, Linton MF, Fazio S, Ichikawa I, Kon V. Nobuhiko A, et al. Among authors: linton mf. Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2143-8. doi: 10.1161/01.ATV.0000145607.03879.e0. Epub 2004 Sep 16. Arterioscler Thromb Vasc Biol. 2004. PMID: 15374850

5

Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.

Babaev VR, Yancey PG, Ryzhov SV, Kon V, Breyer MD, Magnuson MA, Fazio S, Linton MF. Babaev VR, et al. Among authors: linton mf. Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1647-53. doi: 10.1161/01.ATV.0000173413.31789.1a. Epub 2005 Jun 9. Arterioscler Thromb Vasc Biol. 2005. PMID: 15947238

6

Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice.

Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF, Ichikawa I, Fazio S, Kon V. Ayabe N, et al. Among authors: linton mf. Atherosclerosis. 2006 Feb;184(2):312-21. doi: 10.1016/j.atherosclerosis.2005.05.016. Epub 2005 Jul 14. Atherosclerosis. 2006. PMID: 16023123

7

Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction.

Suganuma E, Zuo Y, Ayabe N, Ma J, Babaev VR, Linton MF, Fazio S, Ichikawa I, Fogo AB, Kon V. Suganuma E, et al. Among authors: linton mf. J Am Soc Nephrol. 2006 Feb;17(2):433-41. doi: 10.1681/ASN.2005080883. Epub 2005 Dec 21. J Am Soc Nephrol. 2006. PMID: 16371432

8

Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.

Suganuma E, Babaev VR, Motojima M, Zuo Y, Ayabe N, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V. Suganuma E, et al. Among authors: linton mf. J Am Soc Nephrol. 2007 Aug;18(8):2311-9. doi: 10.1681/ASN.2006090967. Epub 2007 Jul 18. J Am Soc Nephrol. 2007. PMID: 17634441

9

Renal dysfunction potentiates foam cell formation by repressing ABCA1.

Zuo Y, Yancey P, Castro I, Khan WN, Motojima M, Ichikawa I, Fogo AB, Linton MF, Fazio S, Kon V. Zuo Y, et al. Among authors: linton mf. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1277-82. doi: 10.1161/ATVBAHA.109.188995. Epub 2009 Aug 10. Arterioscler Thromb Vasc Biol. 2009. PMID: 19667109 Free PMC article.

10

Atherosclerosis in chronic kidney disease: the role of macrophages.

Kon V, Linton MF, Fazio S. Kon V, et al. Among authors: linton mf. Nat Rev Nephrol. 2011 Jan;7(1):45-54. doi: 10.1038/nrneph.2010.157. Epub 2010 Nov 23. Nat Rev Nephrol. 2011. PMID: 21102540 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters